Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-08

Clinical Trial Update: Randomized Controlled Trial of Vaginal Progesterone in Women With Threatened Preterm Labor [Phase 4]

View source ↗

Summary

A Phase 4 randomized controlled trial evaluating vaginal progesterone for threatened preterm labor has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Progesterone (vaginal) (progesterone)

Snippet

Sponsor: University of Calgary | Conditions: Obstetric Labor, Premature | Phase 4 | Status: TERMINATED